TNF-α-induced matrix Fn disruption and decreased endothelial integrity are independent of Fn proteolysis

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 275, Issue 1 19-1, 1998, Pages

  Curtis, Theresa M ^a   Rotundo, Robert F ^a   Vincent, Peter A ^a   McKeown Longo, Paula J ^a   Saba, Thomas M ^a  

^a ALBANY MEDICAL COLLEGE   (United States)

Author keywords

Fibronectin; Lung vascular permeability; Proteinases; Tumor necrosis factor

Indexed keywords

FIBRONECTIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; BLOOD VESSEL PERMEABILITY; CATTLE; EXTRACELLULAR MATRIX; LUNG BLOOD VESSEL; LUNG INJURY; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL; PROTEIN DEGRADATION;

EID: 0031845940     PISSN: 10400605     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajplung.1998.275.1.l126     Document Type: Article

References (38)

1. Brigham, K. L., and B. Meyrick. Endotoxin and lung injury. Am. Rev. Respir. Dis. 133: 913-927, 1986.
2. Burridge, K., K. Fath, T. Kelly, G. Nuckolls, and C. Turner. Focal adhesions: transmembrane junctions between the extracellular matrix and the cytoskeleton. Annu. Rev. Cell Biol. 4: 487-525, 1988.
3. Christopher, R. A., A. Kowalczyk, and P. J. McKeown-Longo. Localization of fibronectin matrix assembly sites on fibroblasts and endothelial cells. J. Cell Sci. 110: 569-581, 1997.
4. Cooper, J. A., P. J. Del Vecchio, F. L. Minnear, K. E. Burhop, W. M. Selig, J. G. N. Garcia, and A. B. Malik. Measurement of albumin permeability across endothelial monolayers in vitro. J. Appl. Physiol. 62: 1076-1083, 1987.
5. 1, or TNF-α exposure. Am. J. Physiol. 269 (Lung Cell. Mol. Physiol. 13): L248-L260, 1995.
6. Daudi, I., T. M. Saba, M. Lewis, E. Lewis, F. A. Blumenstock, P. Gudewicz, A. B. Malik, and J. W. Fenton. Fibronectin fragments in lung lymph after thrombin-induced lung vascular injury. Lab. Invest. 61: 539-547, 1989.
7. Goldblum, S. E., X. Ding, and J. Campbell-Washington. TNF-α induces endothelial cell F-actin depolymerization, new actin synthesis, and barrier dysfunction. Am. J. Physiol. 264 (Cell Physiol. 33): C894-C905, 1993.
8. Hanemaaijer, R., P. Koolwijk, L. Le Clercq, W. J. A. De Vree, and V. W. M. Van Hinsbergh. Regulation of matrix metalloproteinase expression in human vein and microvascular endothelial cells. Biochem. J. 296: 803-809, 1993.
9. Hodivala, K. J., and F. M. Watt. Evidence that cadherins play a role in the downregulation of integrin expression that occurs during keratinocyte terminal differentiation. J. Cell Biol. 124: 589-600, 1994.
10. Laemmli, U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680-688, 1970.
11. Madri, J. A., S. K. Williams, T. Wyatt, and C. Mezzio. Capillary endothelial cell cultures: phenotypic modulation by matrix components. J. Cell Biol. 97: 153-165, 1983.
12. McKeown-Longo, P. J., and D. F. Mosher. Binding of plasma fibronectin to cell layers of human skin fibroblasts. J. Cell Biol. 97: 466-472, 1983.
13. Mooney, D. J., R. Ranger, and D. E. Ingber. Cytoskeletal filament assembly and the control of cell spreading and function by the extracellular matrix. J. Cell Sci. 108: 2311-2320, 1995.
14. Niedbala, M. J., and M. S. Picarella. Tumor necrosis factor induction of endothelial cell urokinase-type plasminogen activator mediated proteolysis of extracellular matrix and its antagonism by gamma-interferon. Blood 79: 678-687, 1992.
15. Partridge, C. A., C. J. Horvath, P. J. Del Vecchio, P. G. Phillips, and A. B. Malik. Influence of extracellular matrix in tumor necrosis factor-induced increase in endothelial permeability. Am. J. Physiol. 263 (Lung Cell. Mol. Physiol. 7): L627-L633, 1992.
16. Partridge, C. A., J. J. Jeffrey, and A. B. Malik. A 96-kDa gelatinase induced by TNF-α contributes to increased microvascular endothelial permeability. Am. J. Physiol. 265 (Lung Cell. Mol. Physiol. 9): L438-L447, 1993.
17. Peters, J. H., M. H. Ginsberg, C. M. Case, and C. G. Cochrane. Release of soluble fibronectin containing an extra type III domain (ED1) during acute pulmonary injury mediated by oxidants or leukocytes in vivo. Am. Rev. Respir. Dis. 138: 167-174, 1988.
18. Rebres, R. A., P. J. McKeown-Longo, P. A. Vincent, E. Cho, and T. M. Saba. Extracellular matrix incorporation of normal and NEM-alkylated fibronectin: liver and spleen deposition. Am. J. Physiol. 269 (Gastrointest. Liver Physiol. 32): G902-G912, 1995.
19. Redl, H., G. Schlag, and H. Lamche. TNF-α and LPS-induced changes of lung vascular permeability: studies in unanesthetized sheep. Circ. Shock 31: 183-192, 1990.
20. 1-containing cellular fibronectin release into lung lymph during lung vascular injury with postoperative bacteremia. Am. J. Physiol. 264 (Lung Cell. Mol. Physiol. 8): L66-L73, 1993.
21. Royall, J. A., R. L. Berkow, J. S. Beckman, M. K. Cunningham, S. Matalon, and B. A. Freeman. Tumor necrosis factor and interleukin 1α increase vascular endothelial permeability. Am. J. Physiol. 257 (Lung Cell. Mol. Physiol. 1): L399-L410, 1989.
22. Saba, T. M. Fibronectin: role in phagocytic host defense and lung vascular integrity. In: Fibronectin in Health and Disease, edited by S. Carsons. Boca Raton, FL: CRC, 1989, p. 49-68.
23. Saba, T. M. Kinetics of plasma fibronectin: relationship to phagocytic function and lung vascular integrity. In: Fibronectin, edited by D. F. Mosher. New York: Academic, 1989, p. 395-439.
24. Saba, T. M., F. A. Blumenstock, D. M. Shah, R. H. Landaburu, M. E. Hrinda, D. C. Deno, J. M. Holman, E. Cho, C. Dayton, and P. M. Cardarelli. Reversal of opsonic deficiency in surgical, trauma, and burn patients by infusion of purified human plasma fibronectin. Am. J. Med. 80: 229-240, 1986.
25. Sims, J. R., S. Karp, and D. E. Ingber. Altering the cellular mechanical force balance results in integrated changes in cell, cytoskeletal and nuclear shape. J. Cell Sci. 103: 1215-1222, 1992.
26. Stephens, R. W., J. Pollanen, H. Tapiovaara, K. Leung, P. Sim, E. Salonen, E. Ronne, N. Behrendt, K. Dano, and A. Vaheri. Activation of pro-urokinase and plasminogen on human sarcoma cells: a proteolytic system with surface-bound reactants. J. Cell Biol. 108: 1987-1995, 1989.
27. Stolpen, A. H., E. C. Guinan, W. Fiers, and J. S. Pober. Recombinant tumor necrosis factor and immune interferon act singly and in combination to reorganize human vascular endothelial cell monolayers. Am. J. Pathol. 123: 16-24, 1986.
28. Torikata, C., B. Villiger, C. I. Kuhn, and J. A. McDonald. Ultrastructural distribution of fibronectin in normal and fibrotic human lung. Lab. Invest. 52: 399-408, 1985.
29. Tracey, K. J., B. Beutler, S. F. Lowry, J. Merryweather, S. Wolpe, I. W. Milsark, R. J. Hariri, T. J. Fahey III, A. Zentella, J. D. Albert, G. T. Shires, and A. Cerami. Shock and tissue injury induced by recombinant human cachectin. Science 234: 470-474, 1986.
30. Tracey, K. J., Y. Fong, D. G. Hesse, K. R. Manogue, A. T. Lee, G. C. Kuo, S. F. Lowry, and A. Cerami. Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia. Nature 330: 662-664, 1987.
31. Van Hinsbergh, V. W. M., T. Kooistra, E. A. Van der Berg, H. M. G. Pricen, W. Fiers, and J. J. Emeis. Tumor necrosis factor increases the production of plasminogen activator inhibitor in human endothelial cells in vitro and in rats in vivo. Blood 72: 1467-1473, 1988.
32. Van Hinsbergh, V. W. M., E. A. Van der Berg, W. Fiers, and G. Dooijewaard. Tumor necrosis factor induces the production of urokinase-type plasminogen activator by human endothelial cells. Blood 75: 1991-1998, 1990.
33. 1 fibronectin from matrix of perfused lungs after vascular injury is independent of protein synthesis. Am. J. Physiol. 265 (Lung Cell. Mol. Physiol. 9): L485-L492, 1993.
34. Wang, H., and D. E. Ingber. Control of cytoskeletal mechanics by extracellular matrix, cell shape, and mechanical tension. Biophys. J. 66: 2181-2189, 1994.
35. Wang, N., J. P. Butler, and D. E. Ingber. Mechanotransduction across the cell surface and through the cytoskeleton. Science 260: 1124-1127, 1993.
36. Werb, Z., P. M. Tremble, O. Behrendtsen, E. Crowly, and C. H. Damsky. Signal transduction through the fibronectin receptor induces collagenase and stromelysin gene expression. J. Cell Biol. 109: 877-889, 1989.
37. Wheatley, E. M., P. J. McKeown-Longo, P. A. Vincent, and T. M. Saba. Incorporation of fibronectin into matrix decreases TNF-induced increase in endothelial monolayer permeability. Am. J. Physiol. 265 (Lung Cell. Mol. Physiol. 9): L148-L157, 1993.
38. Wheatley, E. M., P. A. Vincent, P. J. McKeown-Longo, and T. M. Saba. Effect of fibronectin on permeability of normal and TNF-treated lung endothelial cell monolayers. Am. J. Physiol. 264 (Regulatory Integrative Comp. Physiol. 33): R90-R96, 1993.